BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36366538)

  • 1. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
    Aslan AT; Balaban HY
    World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.
    Todt D; Walter S; Brown RJ; Steinmann E
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27754363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E in Germany--an under-reported infectious disease.
    Pischke S; Behrendt P; Bock CT; Jilg W; Manns MP; Wedemeyer H
    Dtsch Arztebl Int; 2014 Sep; 111(35-36):577-83. PubMed ID: 25249359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of hepatitis E that developed during chemotherapy for malignant lymphoma and responded to ribavirin.
    Hashimoto S; Fukuda H; Takeda K; Uchida K; Sanuki F; Akiyama T; Kondo E; Wada H
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1957. PubMed ID: 38124270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate, an anti-inflammatory drug, inhibits Hepatitis E viral replication.
    Kumar A; Hooda P; Puri A; Khatter R; S Al-Dosari M; Sinha N; Parvez MK; Sehgal D
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2280500. PubMed ID: 37975328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections.
    Lhomme S; Marion O; Abravanel F; Izopet J; Kamar N
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31991629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of virus‒host recombinant variants of the hepatitis E virus.
    Paronetto O; Allioux C; Diméglio C; Lobjois L; Jeanne N; Ranger N; Boineau J; Pucelle M; Demmou S; Abravanel F; Chapuy-Regaud S; Izopet J; Lhomme S
    J Virol; 2024 May; ():e0029524. PubMed ID: 38712945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients.
    Rivero-Juarez A; Vallejo N; Lopez-Lopez P; Díaz-Mareque AI; Frias M; Vallejo A; Caballero-Gómez J; Rodríguez-Velasco M; Molina E; Aguilera A
    Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31888090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Hepatitis E Virus Manifesting as Elevated Transaminases in a Heart Transplant Patient.
    Mohamed I; Sanders K; Hillebrand DJ
    ACG Case Rep J; 2024 Mar; 11(3):e01308. PubMed ID: 38524259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus.
    Corneillie L; Lemmens I; Montpellier C; Ferrié M; Weening K; Van Houtte F; Hanoulle X; Cocquerel L; Amara A; Tavernier J; Meuleman P
    Cell Mol Life Sci; 2023 Oct; 80(11):326. PubMed ID: 37833515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Food Homogenates on Cell Survival In Vitro.
    Semaan D; O'Connor L; Scobie L
    Food Environ Virol; 2024 Mar; ():. PubMed ID: 38499912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three Distinct Reporter Systems of Hepatitis E Virus and Their Utility as Drug Screening Platforms.
    Primadharsini PP; Nagashima S; Nishiyama T; Okamoto H
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform.
    Nagashima S; Primadharsini PP; Nishiyama T; Takahashi M; Murata K; Okamoto H
    J Virol; 2023 Sep; 97(9):e0050823. PubMed ID: 37681960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Characterization of Efficient Cell Culture Systems for Genotype 1 Hepatitis E Virus and Its Infectious cDNA Clone.
    Primadharsini PP; Nagashima S; Tanaka T; Jirintai S; Takahashi M; Murata K; Okamoto H
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin.
    Primadharsini PP; Nagashima S; Takahashi M; Murata K; Okamoto H
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
    Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
    mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hepatitis E virus.
    Dalton HR; Kamar N
    Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.